chrisvoncsefalvay/vaers-outcomes huggingface dataset:
The patient was being monitored post vaccination.  I noticed (RPh) that pt was leaning back in the chair and making a snoring noise.  On closer inspection his eyes were closed, body limp, and head back.  We tried to ask if he was ok and grabbed his arm and held him up.  We were getting ready to place him on the ground and he regained consciousness.  Patient said after vaccine he became drowsy and sweaty. Incidence lasted 2 minutes and he stayed at the pharmacy for at least 30 minutes post vaccine.
Uncontrollable shaking/convulsions lasting about 45 minutes from onset at 6am accompanied by intense upper arm pain in injection arm. Low fever around 99 degrees Fahrenheit lasting most of the day. Arm pain diminished after a few hours and was a more mild throughout the remainder of the day into the next day. No treatment administered.
Headache,  fever, muscle aches (especially my fingers) extreme exhaustion and brain fog. Tylenol is helping. Symptoms just started this morning
Almost immediately after vaccines she got erythematous macular rash and then with 10-15 min hives on arms and legs large (6-8 cm) local reaction; also with some facial and foot swelling. BENADRYL and 30mg prednisone within 2 hours much better.
Patient is 4-months pregnant, not vaccinated since 2015/2016, husband vaccinated prior to patient's pregnancy. Patient is bleeding and clotting. See attached.   September 12, 2021 To Whom It May Concern,  Around the third week of August, I received a call from my daughter. She stated that she was bleeding. She was approximately 4-months pregnant when she called. She went to her doctor and the doctor detected a heartbeat from the baby and dismissed her bleeding concerns. She continues to bleed and clot. She went back in, had an ultrasound, the baby appeared to be developing normally. Her family practitioner is [redacted], phone [redacted] and her OB/GYN is [redacted], phone [redacted]. Patient brought up the vaccine issue with one of her doctors. He or she said something to the effect of I suppose it's a possibility, but the doctors(s) failed to press the issue. Patient was told to "take it easy". What does "take it easy" look like when you have a  vaccine injured 5-yr old, a vaccine injured 2-yr old, and a 1-yr old to feed, bath, teach, etc. and a husband whose too busy chain smoking, taking 'medicine', on his phone doing research, and too busy and 'stressed' working 40-hours a week to life a finger to help?  I am writing this because patient's second husband got the CoVid-19 vaccine earlier this year, prior to patient getting pregnant. Patient is vaccine injured herself, understands the dangers and has not received any vaccines since she was coerced by her first husband to get not one, but TWO flu shots during her first pregnancy with her first born (I've filed at least FIVE reports on his cumulative injuries). This pregnancy is her fourth pregnancy. I attempted to get the needed information from husband through patient and he refused, claiming medical privacy of course. The best I can tell you is where patient received the "FREE" CoVid-19 vaccine. Patient probably received the vaccine at the store pharmacy in March or April, the store where he and patient work. The pharmacies phone is [redacted]. Husband and patient's address is [redacted]. Patient's cell phone number is [redacted] and husband's cell phone number is [redacted]. Husband is in his early 40's. Patient is 35 years old.   Patient had no bleeding or clotting with her first three pregnancies. From my extensive research regarding vaccines, it is my belief the CoVid-19 vaccine, through transmission, which is different than shedding, effects how everything including sperm. We all know how safe thalidomide proved to be. This "vaccine", I believe is causing the growing numbers of miscarriages, bleeding, clotting, and deaths as documented in the reporting system.  I know your numbers are highly underreporte3d. I have tried to stay on top of the injuries my grandchildren have suffered, but it's difficult when I'm denied opportunities to spend time with them and observe their speech, behaviors, gait, social and emotional development, etc.  Update as of September 16, 2021 patient reported that she has not bled/clotted in the last two days.   Mother/Advocate
Extreme vertigo when I move my head or rub my eyes, worsened by bending over or rolling onto side when lying down.
Pneumonia and enlarged heart fluid in my lungs hard time breathing only 10% heart function now, also have a blood clot in my heart
Information has been received from a registered nurse concerning an 13-year-old male with no allergies or medical history who was vaccinated SC with a 0.5 mL dose of varicella virus vaccine live (lot # 649440/0116R). There was no concomitant medication. On 29-AUG-2005, the patient was seen in the office with a rash on his whole body which started on his ears on 25-AUG-2005 or 27-AUG-2005. He had 20 lesions, some had vesicles, some were crusted. He was treated with fexofenadine hydrochloride (ALLEGRA) 30 mg tab, two tabs BID. No diagnostic laboratory tests were performed. A product quality complaint was not involved. Additional information has been requested.
This spontaneous report as received from a Certified Medical Assistant refers to an unspecified number of patients of unknown age and gender. The patient's medical history and concurrent conditions were not reported. On an unknown date the patients were vaccinated with an improperly stored doses of VARIVAX (Merck) (dose was not reported), lot # L003774, expiration date 04-FEB-2015. The patient's concomitant therapies were not reported. No adverse effects were reported. Lot number L003774 has been verified to be a valid lot number for VARIVAX. Additional information has been requested.
AT APPROXIMATELY 3:53 PM, PATIENT EXPERIENCED DIZZINESS AND FAINTING AND IT WAS NOTIFIED TO PHARMACY STAFF BY THE PATIENT'S SISTER.  PATIENT WAS ABLE TO SIT UP AND THEN PROCEED TO LAY DOWN ON A COT.  VITALS WERE TAKEN AT 3:54 PM AND REASSESSED AT 4:07 PM.  PATIENT'S DIZZINES SYMPTOM RESOLVED AND WAS ABLE TO LEAVE WITH HIS SISTER.  A PHONE CALL WAS MADE TO THE PATIENT AT 5:15 PM AND PATIENT STATED THAT HE IS NO LONGER FEELING ANY DIZZINESS.
hives; fatigue; arm is hot; arm swollen and later csame in the news as Moderna Arm; Redness in the arm (dime-sized); Headache; Earache; Pain in arm; This spontaneous case was reported by a physician and describes the occurrence of MYALGIA (Pain in arm) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Soy allergy, Shellfish allergy and Egg allergy.    On 05-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Jan-2021, the patient experienced MYALGIA (Pain in arm). At the time of the report, MYALGIA (Pain in arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported.  No treatment information was provided.    Most recent FOLLOW-UP information incorporated above includes: On 24-Jan-2021: No specific follow-up information recorded. On 23-Jun-2021: Non-Significant follow-up Appended
Mom states 2 hrs p/receiving DTP 12SEP91 pt became ill w/t105, cough, "mouth broke out w/sores, diarrhea, took to ER x 2;
Swollen at injection site approximately 3 inch diameter with soreness and fever. Difficulty concentrating. Tingling in fingers on left arm (arm that was injected. Symptoms began at 6am on morning following injection and continued for 36 hours.
STOMACH  STARTED HURTING OFF AND ON. WENT ON FOR TWO DAYS, THEN STOPPED.
Menveo and Boostrix administered not on the deltoid muscle and SC instead of IM.; This non-serious case was reported by a nurse via call center representative and described the occurrence of intramuscular formulation administered by other route in a patient who received Men ACWY-CRM NVS (Menveo) for prophylaxis.   Co-suspect products included DTPa (Reduced antigen) (Boostrix) for prophylaxis.   On an unknown date, the patient received Menveo (subcutaneous, unknown deltoid) and Boostrix (subcutaneous, unknown deltoid). On an unknown date, an unknown time after receiving Menveo and Boostrix, the patient experienced intramuscular formulation administered by other route (Verbatim: Menveo and Boostrix administered not on the deltoid muscle and SC instead of IM.). The outcome of the intramuscular formulation administered by other route was unknown.   Additional Information: GSK receipt date: 11-AUG-2023 Regular Nurse (RN) was looking information to share with the physician about Menveo and Boostrix administered not on the deltoid muscle and subcutaneously instead of Intramuscular. Health care professional (HCP) mentioned that there was a patient involved but there was no data available that she could provided to GSK and Manager of Quality Department of Health was doing a report and a follow up on this case. The patient received Boostrix and Menveo via subcutaneously instead of intramuscularly, which led to Intramuscular formulation administered by other route. The reporter did not consent to follow up.
Delayed hypersensitivity reaction on left arm where injection was given. Red circular rashes, slight itching- treated with oral Benadryl and topical antihistamine cream.
Body aches, migraine, chills, dizziness, nausea  Missed work, treated successfully with APAP
ALL SEVERE AND STILL EXIST TODAY. Fevers, mouth ulcers, body stiffness, full body pain, dizziness, heart palpitations, nausea, diarrhea, stomach cramps, stomach bloating, fainting spells.
01-08-21 - headache; injection site sore 01-09-21 - headache; injection site sore 01-10-21 - headache; injection site sore 01-11-21 - headache; injection site sore, injection site redness; injection site warm to touch
Muscle pain; This case was reported by a consumer via call center representative and described the occurrence of muscle pain in a adult male patient who received Herpes zoster (Shingrix) for prophylaxis.   On 4th August 2019, the patient received Shingrix. In August 2019, less than a week after receiving Shingrix, the patient experienced muscle pain. On an unknown date, the outcome of the muscle pain was not recovered/not resolved.   It was unknown if the reporter considered the muscle pain to be related to Shingrix.  Additional case details were reported as follows: The age at vaccination was not reported. The patient received the Shingrix vaccine last Sunday and he was still experiencing muscle pain. The patient refused follow up and did not want to answer any questions. The reporter denied permission to follow up.  In the XML document outcome of events was reported as recovering, but in database its mentioned as not recovered, so kept as reported in database
Began 12/11/99 with rash on face adn now on trunk and abdomen. Exposed to CP at school.
1st dose 18Nov2022, 2nd not yet; This case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a 65-year-old male patient who received HBV (Engerix B) for prophylaxis.   Co-suspect products included hepatitis B vaccine pre-filled syringe device (Engerix B Pre-Filled Syringe Device) injection syringe for prophylaxis.   Previously administered products included Engerix B (received 1st dose (1 ml) in unknown deltoid via intramuscular route (batch number: N4GA4 and expiry date 2nd January 2023) on 18th November 2022).   On an unknown date, the patient did not receive the 2nd dose of Engerix B and Engerix B Pre-Filled Syringe Device. On an unknown date, unknown after receiving Engerix B and Engerix B Pre-Filled Syringe Device, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK Receipt date:10-Feb-2023. Reporter's Comment: The vaccine administration facility (for 1st dose) was the same as primary reporter. The reporter consented to follow-up. Additional Supportive Information: Till the time of reporting, the patient did not receive 2nd dose of Engerix B vaccine, which led to incomplete course of vaccination. The VAERS details were reported for 1st dose.
He had his 2nd pfizer vaccine on 5/3/21 The next day he felt tired 2 days later (on 5/5) he started with fever, chills and body aches He then started with abdominal pain --hurt to take a breath in, he could not lay flat  He went to Hospital and was dx with myocarditis   He was started on ibuprofen (changed to naproxen for discharge), colchicine and protonix
On August 3rd I had a sore throat cold, sinus infection type of thing. I went to urgent care to get a rapid covid test, by the time I got there I felt super sick. I took a COVID test and the next day they had results, positive for covid. I had headaches, a cough that would not go away. I had to take a prescription cough medication. I was extremely congested but it never went down into my chest. My cough lasted for about a month. The cold and flu symptoms lasted for about 2 weeks. I also lost my taste and smell. I am just now starting to be able to smell again, still no taste.
Patient waited 30 minutes past vaccine given due to past allergic reactions stated. She stated throat scratchy, stomach a little, funny. I told her she could wait and be monitored. She carries eip pen for reactions. She stated no and wanted to go. I told her I would follow up with a phone call. I spoke to her at roughly noon she stated took 2 Benadryl and feeling better. Tongue was numb "like she had been to dentist" . I did a second follow- up call and advised her to seek medical attention due to Benadryl make not last long in her system and tongue could still swell on or trouble breathing.
Within 5 minutes: Throat tightness; headache; face numbness; tongue numbness. After 40-minutes: Extreme sensitivity to light; loss of vision clarity; headache worsening. Face and tongue numbness cleared. 2-3 days: Flu-like symptoms; pain/stiffness in neck; loss of clear distance vision (could no longer read street signs). July 2021: Distance vision still not restored requiring PRK surgery to aid in regaining some of the vision.
right thigh erythema and induration measuring 11.6 x 8.4 cm
Lost my voice today; Woke up with splitting headache; Every spot was hurting; I was too sick to take pain medicine yesterday; Ended up with terrible pain in ear; Pain in jaw; Pain in hip replacement leg; I had sharp pain where my lymph nodes were removed; I  was laying in bed all day today; I thought I was going to die; My mouth was dry; This spontaneous case was reported by a consumer and describes the occurrence of EAR PAIN (Ended up with terrible pain in ear), PAIN IN JAW (Pain in jaw), PAIN IN EXTREMITY (Pain in hip replacement leg), PAIN (I had sharp pain where my lymph nodes were removed) and BEDRIDDEN (I  was laying in bed all day today) in an 83-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. Unknown, Unknown and 037F21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Hip replacement (Patient recently had hip replacement.). Concurrent medical conditions included Breast cancer. Concomitant products included TAMOXIFEN for Breast cancer.   In February 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In March 2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 23-Sep-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 23-Sep-2021, the patient experienced EAR PAIN (Ended up with terrible pain in ear), PAIN IN JAW (Pain in jaw), PAIN IN EXTREMITY (Pain in hip replacement leg), PAIN (I had sharp pain where my lymph nodes were removed), BEDRIDDEN (I  was laying in bed all day today), FEELING ABNORMAL (I thought I was going to die), DRY MOUTH (My mouth was dry), ILLNESS (I was too sick to take pain medicine yesterday) and MYALGIA (Every spot was hurting). On 24-Sep-2021, the patient experienced DYSPHONIA (Lost my voice today) and HEADACHE (Woke up with splitting headache). The patient was treated with CISAPRIDE (MOBID) for Adverse event, at an unspecified dose and frequency. At the time of the report, EAR PAIN (Ended up with terrible pain in ear), PAIN IN JAW (Pain in jaw), PAIN IN EXTREMITY (Pain in hip replacement leg), PAIN (I had sharp pain where my lymph nodes were removed), BEDRIDDEN (I  was laying in bed all day today), FEELING ABNORMAL (I thought I was going to die), DRY MOUTH (My mouth was dry), DYSPHONIA (Lost my voice today), ILLNESS (I was too sick to take pain medicine yesterday), HEADACHE (Woke up with splitting headache) and MYALGIA (Every spot was hurting) outcome was unknown.            Patient got an implant in her mouth.  Patient took some pain medicine today and is feeling better.  Treatment details include Heating pad for pain in ears, Drinking a lot of liquids.   This case was linked to MOD-2021-330687 (Patient Link).
Received MMRV Vaccination on 4/4/19 at 3:00 pm. On 4/6/19 approx 4 pm child began to hallucinate that bugs were crawling all over her. No fever or other symptoms present. This episode lasted roughly 9 hrs where child was tearing off clothes and attempting to remove herself from car seat as she was hallucinating that she was covered in bugs, they were biting her and crawling in and out of her anus and vagina. No bugs present. 4/9/19 after consulting with Pediatrician child was taken to Clinic. Full drug screening by urine was clear. Bloodwork done for ASO Titers and Drug Panel. Still waiting on results. Doctor suggested PANDAS. Amoxicillin was started 400 mg twice per day. 4/11/19 Received call from daycare that child was hallucinating (no fever present) and terrified that bugs were crawling all over her at about 11:00 am. 4/12/19 4:00 am Child was hallucinating that bugs were crawling all over her and absolutely terrified. Child has had blank stare since and OCD tendencies. 4/14/19 Child vomiting from approx 9:30 am to 10:15 am no fever present. Doctors appt scheduled with Pediatrics for 4/15/19 at 3:00 PM. Dr. has cleared his schedule to see her and we were advised if she continues to deteriorate to bring her to Hospital.
Administrative error- The vaccine was given to a 17 year old male, which is outside EUA.  No adverse events related to the vaccine.
Information has been received from a healthcare worker referring to unspecified patients of unknown age and gender. On 16-APR-2015, the patients were vaccinated with improperly stored doses of LIQUID PEDVAXHIB (lot number, dose and route were unknown). No adverse effects were reported. This is one of several reports received from the same reporter. Additional information has been requested.
Patient developed a large red rash (approximately 10 1/2 inches x 5 1/2 inches) the day after administration of the vaccine. It was red and warm, but patient reported no pain. Her doctors office told he to take BENADRYL for a couple of days. Patient reported to me that she forgot to take the medication, but the rash healed. She was seen by her physician's nurse for routine testing of INR for her warfarin when she reported the rah. The nurse notified me and requested that I fill-out this form.
Headache- immediately after injection Nausea- 1pm Fatigue-1pm Injection site pain -9 am Dizziness-2pm Fever-2 pm
This spontaneous report was received from a registered nurse refers to a patient of unknown age and gender. On an unknown date, the patient was vaccinated with GARDASIL 9 (dose, frequency and route were not reported) (lot# K010215 and expiration date 05-MAY-2017) and confirmed not GARDASIL (quadrivalent). M-M-R II and PNEUMOVAX23 appeared on the product list, because stability questions were asked about these products and no doses of improperly stored M-M-R II and PNEUMOVAX23 were administered. No adverse effects were reported. No Product Quality Product (PQC) was involved. This is one of the several reports received from the same source. Additional information has been requested.
1st dose 6/13/2019, 2nd dose 2/18/2022; This case was reported by a pharmacist via call center representative and described the occurrence of drug dose administration interval too long in a 74-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (received 1st dose on 13th June 2019).   On 18th February 2022, the patient received the 2nd dose of Shingrix. On 18th February 2022, unknown after receiving Shingrix, the patient experienced drug dose administration interval too long. On an unknown date, the outcome of the drug dose administration interval too long was unknown.  Additional details were provided as follows: The patient received the 2nd dose of Shingrix later than the recommended schedule, which led to lengthening of vaccination schedule. The reporter wanted to inquire and report on how to proceed with Shingrix series, would the patient need to receive 2 doses or an additional dose. The reporter was unable to provide vaccine details. The reporter did not consent to follow up.
This spontaneous report as received from a pharmacist refers to a patient of unknown age and gender. on 19-SEP-2013 the patient was inadvertently vaccinated with a dose of PNEUMOVAX 23 (dose and lot number not provided), subcutaneous in the triceps, instead of a dose of ZOSTAVAX (Merck). No adverse events were reported. Additional information has been requested.
Rash all over. Started 2 hours after injection, controlled with BENADRYL. Getting better.
pt rcvd vax; swollen inject site; warm; red/blue color; painful to walk; pt fussy;
Abdominal pain, dizziness, severe malaise, myalgia, headache,  nausea, sore throat. Sought medical assistance on 7/29/2021.   Treated with RX for bed rest, fluids and ibuprofen prn. Negative COVID test. Heart palpitations  Lingering dizziness for 3 months after illness onset. Lingering abdominal pain (COLON and EGD on 10/28/21) Subsequent 40 lb weight loss since 7/02/2021. Abdominal and Pelvic CT to be done in February 2022 severe gastritis noted per MD).
Client fainted after receiving MCV4, Hep A, and Hep B. Client came to after about 5 seconds. Client
Received DTAP at the PHD, 2 days prior to being seen in our office. Came to office with left shoulder, red and swollen, tender to touch.
Tingling in hands resulting in pain and numbness in hands, arms, legs, feet, toes. Difficulty breathing & muscle weakness. Unable to walk or care for self. Pain medication & supplements to nourish nervous system - change in diet. Resulted in CIDP.
minor tingling on lips and Tongue; This spontaneous case was reported by a consumer and describes the occurrence of PARAESTHESIA ORAL (minor tingling on lips and Tongue) in a 52-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030N20A) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Feb-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PARAESTHESIA ORAL (minor tingling on lips and Tongue). At the time of the report, PARAESTHESIA ORAL (minor tingling on lips and Tongue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not provided. Treatment information was not reported.
Arm soreness at injection site, worse than a flu shot and starting an hour after the shot and lasting approx 2 days.  Increased phelgm production for approx 24 hours following injection.